Nanavati Max Hospital Hosts LIVCON Mumbai 2026, Advancing Outcomes in Liver Critical Care and Transplant Medicine
Reinforcing its leadership in advanced liver care, the Centre for Liver, Intestine and Pancreas Sciences at Nanavati Max Super Speciality Hospital successfully hosted LIVCON Mumbai 2026 recently, a three-day premier conference on ‘Optimising Outcomes in Liver Critical Care’.
The conference brought together over 600 delegates, including leading national experts, eminent faculty, and clinicians from across disciplines, making it one of the most significant academic gatherings in the field of liver critical care in India. LIVCON 2026 served as a high-impact platform for knowledge exchange, spotlighting the latest advancements in liver failure management, transplant pathways, and critical care interventions.
The conference was held under the patronage of Mr Abhay Soi, Chairman and Managing Director, Max Healthcare, and led by a distinguished scientific committee from Nanavati Max Hospital comprising Dr Samir R. Shah, Chairman – Hepatology & Liver Intensive Care; Dr Abdul S. Ansari, Senior Director – Critical Care; and Dr Gaurav Chaubal, Director – Liver and Multi-Organ Transplant.
The scientific programme highlighted a multidisciplinary and protocol-driven approach to managing complex liver conditions. Key sessions addressed critical areas such as brain-related complications due to liver disease, kidney dysfunction, infection management in liver ICUs, bleeding and transfusion practices, and acute-on-chronic liver failure. Experts also deliberated on real-world challenges in transplant decision-making from intensive care settings, alongside emerging areas such as endohepatology.
Adding strong practical value, the conference featured hands-on workshops and live demonstrations, including training on Continuous Renal Replacement Therapy (CRRT) and Plasma Exchange (PLEX)—both vital life-support therapies for critically ill liver patients. A live robotic surgery workshop offered participants insights into next-generation minimally invasive techniques in hepatobiliary and liver transplant procedures.
Speaking about the conference, Dr Samir R. Shah said, “LIVCON Mumbai 2026 reflects our commitment to building a high-impact academic platform that addresses the real-world complexities of liver critical care. The strong participation highlights the growing need for collaborative, multidisciplinary, and protocol-driven approaches to improve patient outcomes.”
Dr Gaurav Chaubal added, “What sets LIVCON apart is its focus on bridging science with clinical practice. By combining expert-led discussions with hands-on learning and live surgical exposure, we are enabling clinicians to translate knowledge into better patient care.”
With robust participation, high-impact scientific discussions, and a strong emphasis on practical learning, LIVCON Mumbai 2026 concluded on a successful note, further strengthening Nanavati Max Hospital’s position as a national centre of excellence in liver critical care and transplant medicine.
Got a story that Healthcare Executive should dig into? Shoot it over to arunima.rajan@hosmac.com—no PR fluff, just solid leads.